Clinical Trial Update: Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)

View source ↗

Summary

The terminated MK-0518-266 trial assessed quality of life in HIV-infected participants who switched to raltegravir versus other antiretroviral regimens; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Immunodeficiency Virus | Status: TERMINATED | Results posted: 2014-10-09